Federal Reserve Economic Data

FRED Economic Data, St. Louis FED

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) After Income Taxes (QFR115385USNO)

Observation:

Q2 2024: 22,521 (+ more)   Updated: Sep 10, 2024 9:09 AM CDT
Q2 2024:  22,521  
Q1 2024:  4,613  
Q4 2023:  8,543  
Q3 2023:  33,837  
Q2 2023:  14,184  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) After Income Taxes [QFR115385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFR115385USNO, .

RELEASE TABLES

Quarterly Financial Report

RELATED DATA AND CONTENT

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Financial Activity Measures Financial Indicators Money, Banking, & Finance

Releases

More Series from Quarterly Financial Report

Tags

Gains/Losses Medicines Pharmaceuticals Quarterly Financial Report Chemicals Finance Nondurable Goods Tax Corporate Goods Income Manufacturing Industry Quarterly Census Nation Public Domain: Citation Requested Not Seasonally Adjusted United States of America

Need Help?

Questions or Comments
FRED Help

Subscribe to the FRED newsletter

Follow us

Back to Top
Top